Skip to content

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

Advancing Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning - a Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05864976
Enrollment
100
Registered
2023-05-18
Start date
2023-12-06
Completion date
2030-01-31
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma Multiforme

Brief summary

This study is investigating the use of a computer algorithm to analyze scans of the brain before surgery to predict how a person's tumor will respond to treatment.

Interventions

DEVICESupport Vector Machine

Machine learning algorithm

Sponsors

Washington University School of Medicine
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must have a radiological diagnosis of a lesion in the brain with characteristics consistent with glioblastoma multiforme. * Must be planning to undergo a pre-operative MRI. * Must be at least 18 years old. * Must be able to understand and willing to sign an IRB approved written informed consent document.

Exclusion criteria

* Contraindication to MRI. * Inability to have clinical follow-up (e.g., patient is out of town and will do follow-up elsewhere).

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who are deemed as short-term survivor or a long-term survivorThrough completion of follow-up (estimated to be 2 years)-Patients will be deemed as a short-term survivor or a long-term survivor and this will be defined as overall survival as less than or greater than 14.5 months, respectively.

Countries

United States

Contacts

CONTACTDimitrios Mathios, M.D.
mathios@wustl.edu314-747-6146
PRINCIPAL_INVESTIGATORDimitrios Mathios, M.D.

Washington University School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026